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Introduction
The immunological synapse (IS) is a specialized cell–cell
junction between a thymus-derived lymphocyte (T cell)
and an antigen-presenting cell (APC) [1,2]. Initiation of an
antigen-specific immune response is based on the interac-
tion between T-cell receptors (TCRs) and major histocom-
patibility complex proteins that have bound antigenic
peptides (MHCps) [3,4]. Because the TCRs and MHCps
are attached to the surface of the T cell and the APC,
respectively, the initiation of an immune response requires
a molecular grasp between the T cell and the APC — a
synapse. A current focus of research on the IS is to deter-
mine how this supramolecular structure contributes to
T-cell sensitivity and to the fidelity of the T-cell response.
Four areas in which the concept of the IS is contributing
to our understanding of T-cell activation are the coordina-
tion of antigen recognition and T-cell migration; the role of
the cytoskeleton in T-cell activation; the mechanism of
sensitive antigen recognition by T cells; and the integra-
tion of the adaptive and innate immune responses.
Historical background
The formation of the IS has been followed over time in live
T cells interacting with planar bilayers [2] and studied at
specific time points in fixed cell–cell conjugates [5]. The T
cell forms an adhesion zone with the antigen-presenting
bilayer; this zone is then surrounded by areas of close
contact where TCR can reach the MHCp. If the TCR
engagement exceeds a threshold rate and level, the T cell
stops migrating and forms a ring of engaged TCRs at the
periphery of the nascent IS (Fig. 1a). This pattern takes
~30 seconds to form and corresponds to the peak of
TCR-associated tyrosine phosphorylation and Ca2+ mobi-
lization. Within a few more seconds, the sites of TCR
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(Print ISSN 1465-9905; Online ISSN 1465-9913)engagement move from the periphery of the contact area
to the center of the contact area to form the mature IS
(Fig. 1b). During this time, the disk-like region of LFA-1–
ICAM-1 (intercellular adhesion molecule-1) interaction
appears to give way to the centrally moving TCR, but the
LFA-1–ICAM-1 interactions maintain the contact area and
evolve into a ring of ~5 µm outer diameter (Fig. 1c). It is
not clear if the same TCRs move from the outside to the
center or if new TCRs are continually recruited. The inter-
action of the TCRs with agonist MHCp complexes has a
short half-life (~5 seconds) [6], and it is known that TCRs
are degraded after effective engagement [7]. However, at
some point in IS formation, the interaction of the TCRs
and the major histocompatibility complex protein (MHC)–
peptide complexes change so that they no longer dissoci-
ate. Thus, while serial engagement may dominate in the
nascent IS, parallel engagement of at least 50 TCRs is
characteristic of the center of the mature IS. These obser-
vations have emphasized the concept that biochemical
reactions are highly compartmentalized in the IS, in such a
way that the location of receptor and signaling molecules
must be considered if we are to to understand the bio-
chemical basis of T-cell activation [8].
Migration and the immunological synapse
T-cell activation requires a sustained signal. The duration
of signaling required to initiate proliferation of T cells is at
least 2 hours [9–11] but may be much longer to achieve
appropriate differentiation of helper T cells [12]. T cells
migrate continually between the blood and the secondary
lymphoid tissues where they encounter APCs. In the
absence of an immune response, the T cell completes this
cycle about twice a day [13]. During the initiation of an
immune response, the T cells are held in the antigen-
exposed lymph nodes or the spleen for 2–3 days and then
effector cells are released after the third day [14]. In vitro
T-cell recognition of agonist MHCp in the context of the
adhesion molecule ICAM-1 delivers a stop signal to
migrating T cells [15]. This stop signal is the first stage in
the formation of an IS [2].
The mechanism of the stop signal is not known, but it
appears to involve the polarization of the T-cell toward the
source of antigen, as indicated by the position of the
microtubule organizing center (MTOC) and the associated
Golgi apparatus [16]. The environment of the T-cell–APC
interaction regulates the stop signal. One example of this
is that APCs with agonist MHCp do not stop T cells in
three-dimensional collagen gels in vitro [17]. The mecha-
nism of this effect is not known, but it may involve
chemokine gradients [18] or interactions with extracellular
matrix that prevent T-cell polarization toward the APCs. In
lymph nodes, however, T cells are not exposed to collagen
fibers, which are sequestered in reticular fibers [19].
Reticular fibers may provide a weakly adhesive reticular
scaffold decorated with APCs that define corridors
through which the T cells migrate [19]. Based on the
lymph node environment and in vitro data, it is most likely
that the IS coordinates T-cell migration and the antigen
recognition process to allow full activation of T cells by
small numbers of APCs that express the appropriate
MHCp. When there are only a few APCs with agonist
MHCp, it seems more efficient to have the T cell stop
upon interaction with agonist MHCp-bearing APCs rather
than having the T cells interact transiently with both
agonist-MHCp-bearing and -deficient APCs equally,
because the former procedure maximizes the interaction
with the agonist MHCp and favors activation early in an
immune response. This view is supported by in vivo data
demonstrating clustering of polarized T cells around den-
dritic cells [20,21].
The cytoskeleton and the immunological
synapse
Our expectations about molecular interaction in the IS
have been shaped by early molecular definition of the mol-
ecules involved in this process [22]. The complex of the
LFA-1 with ICAM-1 (~48 nm) is more than three times as S120
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Figure 1
The development of the immunological synapse. Images adapted from
[2] based on fluorescence microscope images of T-cell interaction with
agonist MHC–peptide complexes (green) and ICAM-1 (red) in a
supported planar bilayer with a T cell. The accumulation of fluorescence
represents interactions in different time frames. (a) Within seconds,
the T cell attaches to the substrate using LFA-1/ICAM-1 interactions in
the center based on TCR signaling triggered at the periphery of the
contact area. (b) Over a period of minutes, the engaged TCRs are
translocated to the center of the contact area. (c) The final pattern,
with a central cluster of engaged TCRs surrounded by a ring of
engaged LFA-1, is stable for hours. Molecular markers for the cSMAC
and pSMAC are indicated. For scale, the pSMAC is ~5 µm across.
ADAP, adhesion and degranulation adapter protein; cSMAC, central
supramolecular activation cluster; ICAM, intercellular adhesion
molecule; LFA, lymphocyte-function-associated antigen; MHCp, major
histocompatibility complex protein complexed to a foreign or self-
peptide; PKC-θ, a protein kinase C isoform that is activated by DAG
but not Ca2+; pSMAC, peripheral supramolecular activation cluster —
the ring of LFA-1 and talin on the T cell and ICAM-1 on the antigen-
presenting cell in the mature immunological synapse; TCR, T-cell
antigen receptor.S121
large as the complex of the TCRs with MHCp (~15 nm)
[23–25]. Therefore, the LFA-1/ICAM-1 and TCR/MHC
interactions segregate into different compartments within
the contact area [26]. This receptor segregation forms
receptor aggregates whose size and organization are
determined by the rigidity of the membrane, the kinetics of
the interactions, and the degree of differences in molecu-
lar size of the participating receptor–ligand pairs [27]. This
immediate segregation may be the initial trigger of recep-
tor clustering and signaling in the nascent IS [28]. These
events take happen in seconds and set the stage for the
formation of the mature synapse.
The formation of the synapse is highly active and depends
on an intact actin cytoskeleton. The formation of the
central cluster of TCR has a superficial similarity to anti-
body-mediated capping, in that it requires an intact actino-
myosin cytoskeleton. A plausible model based on this
similarity has been proposed and initial results support
some aspects of the model [29]. However, the IS has
many elements that are completely absent in capping of
cross-linked antigen receptors. For example, most capping
is based on a network of interactions on a membrane
surface that lead to cross-linking, whereas receptor aggre-
gation is a cell–cell contact is more likely to result from
membrane fluctuations, receptor–ligand size differences,
and interaction kinetics. These components have been
incorporated in a physical model by Chakraborty and col-
leagues [27]. The predictions of this model are remarkably
concordant with the observations on the formation of the
IS. This more physical view is compatible with an active
role for the cortical cytoskeleton, because signaling-
induced changes in cytoskeletal dynamics in activated
T cells will profoundly regulate the Brownian bending
movements of the membrane that are required for move-
ment of the receptor interactions. This model could be
described as a physical and mathematical elaboration on
the kinetic-segregation model [28]. Thus, the early signals
from the TCRs that trigger increased actin polymerization
may induce the membrane fluctuations that drive the matu-
ration of the IS. Both the capping and the kinetic-segrega-
tion models predict that cytoskeletal dynamics are critical
for IS formation.
Signaling pathways activated during synapse
formation
The TCR activates three major transcription-factor fami-
lies. In addition to regulation of gene expression, interme-
diates and side branches of these signaling pathways also
appear to be partly responsible for formation of the
immuological synapse. The importance of this concept is
that these signaling pathways play an important role in
creating the physical environment for sustained signaling.
The initial events at the engaged TCR activate a tyrosine
kinase cascade that requires the participation of three
families of tyrosine kinases: the src family, the syk family,
and the tec family. The src family kinase p56lck and the syk
family kinase ZAP-70 are sufficient for phosphorylation of
the immunotyrosine activation motifs (ITAMs) in the cyto-
plasmic domains of the TCR complex [30]. These
phosporylation events then enable tyrosine phosphoryla-
tion of the transmembrane adapter protein called linker of
activated T cells (LAT), and phosphoLAT recruits enzymes
including phospholipase Cγ (PLCγ), the Grb2/SOS
complex, phosphatidylinositol-3-kinase and the GADS/
SLP-76/NCK/VAV complex [31], which links LAT to activa-
tion of the small G protein Rac and recruitment of PKC-θ.
The recruitment of PLCγ leads to cleavage of phospatidyl-
inositol-4,5-bisphosphate (PI-4,5-P2) to diacylglycerol
(DAG) and inositol-1,4,5-trisphosphate (IP3). IP3 activates
Ca2+ channels in the endoplasmic reticulum to release
Ca2+ into the cytoplasm, and depletion of this store opens
plasma-membrane capacitative Ca2+ channels that enable
sustained cytoplasmic Ca2+ elevation [32]. Full activation
of PLCγ for sustained Ca2+ signals requires activation of
members of the Tec family protein kinase, Itk, which is
recruited to the membrane PI-3,4,5-P3, a product of phos-
phatidylinositol-3-kinase activation. Sustained Ca2+ eleva-
tion activates calcineurin, leading to dephosphorylation
and nuclear translocation of NFAT (nuclear factor of acti-
vated T cells) [33]. The activation of RAS by Grb2/SOS
and also by Ras-GRP leads to activation of AP-1 (activa-
tion protein 1). Activation of AP-1 is also promoted by the
Jun kinase, which is regulated by p21rac downstream of
VAV and other guanine nucleotide exchange factors. The
third major family of transcription factors activated by the
TCR is the PKCθ/IκB/inhibitor of κB kinase pathway
leading to phosphorylation and degradation of IκB, the
regulatory subunit of the nuclear factor-κB (NF-κB) tran-
scription factor [34]. All three of these pathways also feed
back on the synapse through effects on the cytoskeleton
and regulation of adhesion. For example, the adhesion and
degranulation protein (ADAP) identifies a signaling
pathway linking the TCR to LFA-1 regulation [35,36].
The mechanisms that turn off signaling in the synapse are
poorly understood. The broad regulatory mechanisms that
have been identified are phosphatases and ubiquitin-
pathway-mediated degradation [37–39]. It is apparent that
activation of tyrosine kinase signaling pathways lead to
recruitment of tyrosine phosphatases that may be involved
in turning off signals. The most notable is SHP-1, an SH2
domain containing tyrosine phosphatase-1 that is deficient
in motheaten mice. The SH2 domains of SHP-1 interact
with immunotyrosine-based inhibitory motifs in the cyto-
plasmic domains of inhibitory receptors such as the killer
inhibitory receptors and receptors expressed in T cells
such as LAIR [40,41]. When an immunotyrosine-based
inhibitory motif is phosphorylated by an active Src family
kinase it recruits SHP-1, which can extinguish downstream
signaling by ITAM-containing receptors [42]. It has also
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been shown that SHP-1 can be recruited to partially phos-
phorylated ITAMs and therefore may play an important role
in negative signaling by antagonist MHCp [39].
The second process that appears to downregulate signal-
ing is TCR degradation through a ubiquitin-mediated
pathway [43]. Ubiquitin is added to substrates by an
enzyme (E1) that is linked to the substrate by an adapter
(E3). The adapter for addition of ubiquitin to the TCR
complex is not known for certain, but may include
members of the cbl family of ring finger domain containing
E3s [44]. Cbl-b has also been implicated in regulating
phosphatidylinositol-3-kinase (PI-3-K) [45]. TCR degrada-
tion takes place both in lysosomes and via the proteo-
some. How the TCR is delivered to the proteosome is not
clear, but some TCR is internalized via clathrin-coated pits.
The relatively fast off-rate for TCR-MHCp interaction sug-
gests that it should be easy for TCR to dissociate from
MHCp prior to internalization. However, studies in planar
bilayers suggest that the kinetics of the TCR–MHCp inter-
action is substantially slower in the central cluster of the IS
than in solution. Photobleaching experiments suggest, in
fact, that the interactions become irreversible [2]. These
irreversible complexes may require a more radical strategy
for their destruction that would involve removal of an entire
large membrane fragment from either the T cell or APC to
accommodate internalization by one cell or the other. Con-
sistent with this, fragments containing MHCp, CD80, and
ICAM-1 are transferred from the APC to the T cell [46,47].
This process results in significant loss of molecules from
the APC but does not reduce the cell’s viability. It is not
clear if the internalized TCR continues to signal before it is
degraded or if all signaling takes place at the cell surface.
When TCR internalization is suppressed by presenting
MHCp on supported planar bilayers, from which the TCR
cannot pull the MHC molecules, it is clear that endosomal
structures collect near the central cluster [48]. These
endosomes contain CD45 and the glycolipid GM1, a
marker for glycolipid- and cholesterol-enriched membrane
domains known as rafts. T cell–APC contacts lack these
synaptic endosomes, perhaps because TCR can extract
MHCp from the APC to achieve internalization of ‘locked
in’ TCR-MHCp interactions. Once the TCR–MHCp inter-
actions are internalized, they may meet CD45- and GM1-
containing endosomes at other sites inside the cell. The
purpose of these endomembrane structures for T-cell acti-
vation is not known. TCR downregulation clearly resets
the threshold of the T cell for subsequent interactions and
thus TCR downregulation can certainly be seen as a
desensitizing mechanism [49].
The role of self MHCp in T-cell sensitivity to
foreign MHCp
Any single TCR interacts with a degenerate spectrum of
MHCp: null MHCps alone do not activate T cells, and
agonist MHCp, the model foreign MHCp, induces full T-
cell activation. Weak agonists induce a subset of T-cell
responses, and antagonists interfere with T-cell responses
to agonists. Approximately half of the TCR–MHCp binding
energy comes from the TCR contacts with the MHC mole-
cule [50]. Thus, the remaining peptides can be further
divided. Some null peptides actively interfere with the TCR
interactions and thus allow no interaction of the TCR with
MHC, while other null peptides are neutral and allow the
TCR to interact with MHC. The kinetics of this latter group
of null MHCp are too fast to induce a response in mature
T cells [51]. Self-peptides that form MHCp that are ago-
nists, weak agonists or antagonists all induce apoptosis of
immature T cells in vivo [51]. In contrast, a subset of null
MHCps enhances positive selection. Thus, most mature T
cells face APCs that are loaded with a mixture of null pep-
tides (self). These mature T cells are triggered by APC
bearing a few agonist/weak agonist MHCp mixed with
diverse null MHCp. Naïve T cells respond to approximately
300 agonist MHCps on the APC, while memory T cells
require only 50 agonist MHCps [52]. A single agonist
MHCp is sufficient to trigger cytotoxic T-cell killing [53].
How is the high sensitivity of immune recognition
achieved? Can a single agonist MHCp achieve T-cell acti-
vation, or do other MHCps promote this process? Wülfing
et al. tested the hypothesis that some null MHCps con-
tribute to T-cell activation through analysis of proliferation
and formation of the IS [54]. They found that an interacting
null MHCp contributes to IS formation and T-cell activa-
tion triggered by subthreshold amounts of agonist MHCp.
It was demonstrated that fluorescently labeled null
MHCps were accumulated in the center of the IS and syn-
ergized with trace levels of agonist MHCp for T-cell actva-
tion. In contrast, the subset of null MHCp that does not
interact with the TCR did not synergize with agonist MHC
for T-cell activation and did not cluster in the center of
synapses. Thus, agonist MHCps do not have to do it
alone: they are substantially helped by this subset of null
MHCps. We propose that this functional subset of
MHCps be termed co-agonists. These experiments
provide proof in principle that very weak TCR–co-agonist
MHCp interactions can contribute to T-cell activation by
the stronger TCR–agonist MHCp interactions. It will now
be important to establish how prominent these synergizing
null MHCps are in the self-peptide repertoire. The density
of these complexes may vary with the specific APC types
and between different TCR and MHC molecules. While
contributing to sensitive recognition of MHCp by T cells, it
is also possible that these null MHCps may contribute to
autoimmune disease.
Integration of adaptive and innate responses
The IS is not limited to adhesion molecules and MHC–
peptide complexes. The activation of naïve T cells involves
a system of checks and balances that are integrated to
make activation decisions. An important aspect of this
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integration is that T cells test both the MHC–peptide
complex and the status of the innate immune response in
the APC. In response to evolutionarily conserved microbial
products such as lipopolysaccharide, the APC can be
become activated. This increases expression of a number
of molecules including the MHCp, adhesion molecules,
and ligands for costimulatory receptors. Ligands for co-
stimulatory receptors include CD80 and B7-DC (also
know at PDL2) [55]. CD28 is the receptor for CD80 and
by binding CD80 it indirectly transduces an innate
immune system signal that can be integrated with the TCR
signal. CD28–CD80 interactions are very inefficient due
to the low density of CD28 and its low lateral mobility on
naïve T cells [56]. Upon immunological synapse formation,
CD28–CD80 interactions are facilitated and focused in
the central region of the immunological synapse, very
close to the site of TCR engagement. However,
CD28–CD80 interaction does not help the TCR–MHCp
interaction, which sets it apart from adhesion molecules
such as LFA-1 and CD2[56]. This suggests a sequential
model for T-cell response to TCR and innate signals. The
formation of the IS corresponds to the antigen signal.
Once this signal is received, the T-cell becomes compe-
tent to receive the signal through CD28. While this is an
attractive hypothesis, there are a number of results that still
must be reconciled. First, Sprent and colleagues have
shown that the CD28–CD80 interaction is very effective at
mediating the transfer of APC membrane proteins to the T-
cell in a process that appears to require adhesion but does
not require antigen [47]. This implies an interaction of
CD28 and CD80 in the absence of TCR signals. The basis
of this interaction is yet to be determined but might involve
preclustering of CD80 on the APC membrane, as recently
reported by Mellman and colleagues [57]. Such precluster-
ing might partially overcome the low expression and mobil-
ity of CD28 on the T cell. It has also been shown that the
MHCp and CD80 do not necessarily have to be presented
on the same APC, in vivo or in vitro [58]. Thus, IS forma-
tion with one APC may facilitate the CD28–CD80 interac-
tion in a contact with a second APC. Additional work will
be required to understand the full implications of the low
mobility of CD28 in diverse interactions in vivo. It will be
important to determine if other secondary signals are
dependent on IS formation.
Future prospects
Studies on the IS are still in their early days. The relation
between IS formation and migration must be explored in
vivo. This is important because it is difficult to simulate the
in vivo environment  in vitro. T cells and APCs can be
labeled  in vitro and transferred into recipient mice or
endogenously labeled through GFP transgenes or knock-in
mutant mice. The likely variables are the local extracellular
matrix and chemokine gradients. This may be approached
either in organ culture or by true in vivo imaging on live
animals with natural perfusion of the lymphoid organs. The
latter will be most important, since afferent lymph is essen-
tial to maintain lymph node architecture and interactions.
Blood perfusion is also likely to be critical to maintain the
viability of cells deep in the lymph node. The depth of
imaging needed can be achieved with two-photon excita-
tion. The relationship between IS formation and the
cytoskeleton needs to be experimentally tested using very
specific genetic, biochemical, and imaging approaches.
The entire question of self-MHCp and the prevalence of
co-agonist MHCp in this group now takes on great impor-
tance. If the proportion of co-agonist MHCp differs
between APCs, then these self-peptides could play an
important role in autoimmunity as well as in normal
responses to pathogens. Finally, the field of co-stimulation
is exploding. There are additional recent members of the
CD28/B7 family of receptors and ligands and there are
also new molecular families that are implicated in providing
co-stimulatory signals. The relation of these signals to the
IS will need to be addressed through genetic, biochemical,
and imaging experiments in the future.
Concluding remarks
In summary, the IS concept provides a number of insights
into the process of T-cell activation. First, it provides a
stop signal that coordinates antigen recognition and T-cell
migration. Second, the essential role of the actin
cytoskeleton in T-cell activation is related to the role of
actin in IS formation. Third, the sensitivity of T-cell to
agonist MHCp is related to the role of weakly interacting,
but probably more abundant, self MHCp in promoting IS
formation. Finally, the IS provides a framework for orderly
integration of the TCR and innate immune signals such as
CD28–CD80 interaction.
Glossary of terms
AP-1 = activation protein 1 — a transcription factor com-
posed of Jun and Fos oncogene products; APC =
antigen-presenting cell — generally a cell dedicated to the
process of generating MHCps from intact antigens and
then interacting with T cells to allow possible TCR-MHCp
interactions and T-cell activation; cSMAC = central
supramolecular activation cluster – the cluster of mole-
cules including TCR and PKC-θ on the T cell and MHC-
peptide complexes on the antigen-presenting cell in the
mature immunological synapse; Grb2/SOS = a complex
that links to phosphorylated LAT and activates guanine
nucleotide exchange and activation of RAS; ICAM-1 =
intercellular adhesion molecule-1 — type I transmembrane
glycoprotein of the immunoglobulin superfamily that inter-
acts with the integrins LFA-1 and Mac-1; IS = immunologi-
cal synapse — the junction between a T cell and an APC
bearing antigenic MHC–peptide complexes; ITAM =
immunotyrosine activation motifs; LFA-1 = lymphocyte-
function-associated antigen-1 — a member of the integrin
family of adhesion molecules that interacts with ICAMs 1,
2, and 3; MHC = major histocompatibility complex
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protein — class I and class II proteins from this gene locus
encode type I transmembrane glycoproteins with peptide-
binding grooves to hold foreign or self-peptides; MHCp =
major histocompatibility complex protein complexed to a
foreign or self-peptide; NFAT = nuclear factor of activated
T cells; PKC-θ = a protein kinase C isoform that is acti-
vated by DAG but not Ca2+; PLCg = phospholipase Cg;
pSMAC = peripheral supramolecular activation cluster —
the ring of LFA-1 and talin on the T cell and ICAM-1 on the
antigen-presenting cell in the mature immunological
synapse; RAS = a small G protein that regulates the
mitogen-activated protein kinase pathway; Ras-GRP = a
protein that mediates an alternative pathway to activation
of Ras that is stimulated by DAG; TCR = T-cell antigen
receptor — type I transmembrane protein generated by
somatic recombination of gene segments to generate mil-
lions of possible MHCp-binding receptors; Two-photon
microscopy = a technique based on using mode-locked
titanium-sapphire lasers to excite fluorescence of visible
light fluorophores with two photons of infrared light. The
use of infrared light provides excellent penetration. The
two-photon excitation is achieved only at the focal point of
the laser beam, so all fluorescence can be collected to
generate the image — even highly scattered photons.
Effective penetration is of the order of 500 mm; VAV = an
oncogene product that acts as a guanine nucleotide
exchange factor for Rac and may also contribute to
recruitment of PKC-θ.
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